| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.493 | 18.568 | 33.224 | 34.897 | 34.250 | 46.157 | - | - | - | - |
| Total Income - EUR | 19.497 | 19.120 | 37.935 | 37.881 | 35.049 | 56.918 | - | - | - | - |
| Total Expenses - EUR | 28.152 | 24.935 | 35.400 | 45.807 | 43.151 | 45.778 | - | - | - | - |
| Gross Profit/Loss - EUR | -8.655 | -5.816 | 2.535 | -7.927 | -8.102 | 11.140 | - | - | - | - |
| Net Profit/Loss - EUR | -9.240 | -6.373 | 1.475 | -8.275 | -8.444 | 10.648 | - | - | - | - |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | - | - | - | - |
Check the financial reports for the company - Amerivit - Health & Therapy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 8.108 | 6.368 | 6.496 | 4.552 | - | - | - | - |
| Current Assets | 8.966 | 23.949 | 28.217 | 9.373 | 15.985 | 23.270 | - | - | - | - |
| Inventories | 1.488 | 4.461 | 10.381 | 8.222 | 4.188 | 2.821 | - | - | - | - |
| Receivables | 7.437 | 7.797 | 179 | 176 | 1.129 | 1.212 | - | - | - | - |
| Cash | 41 | 11.691 | 17.657 | 975 | 10.667 | 19.237 | - | - | - | - |
| Shareholders Funds | -40.062 | -46.026 | -43.772 | -51.244 | -58.696 | -46.935 | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | - | - | - | - |
| Debts | 49.061 | 70.134 | 80.202 | 67.038 | 81.188 | 74.797 | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Amerivit - Health & Therapy Srl